The use of databases in primary immunodeficiencies

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 6, 2014, Pages 501-508

  Kindle, Gerhard ^a   Gathmann, Benjamin ^a   Grimbacher, Bodo ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Database; Primary immunodeficiency; Primary immunodeficiency diseases; Registry

Indexed keywords

ASIA; AUSTRALIA AND NEW ZEALAND; CHINA; DATA BASE; DISEASE REGISTRY; EGYPT; FRANCE; FUNDING; GERMANY; HUMAN; IMMUNE DEFICIENCY; INDIA; INTERNATIONAL COOPERATION; IRAN; MALAYSIA; MEDICAL SOCIETY; MOROCCO; OMAN; PRIORITY JOURNAL; REVIEW; SOUTH AND CENTRAL AMERICA; UNITED KINGDOM; COMMON VARIABLE IMMUNODEFICIENCY; FACTUAL DATABASE; REGISTER;

COMMON VARIABLE IMMUNODEFICIENCY; DATABASES, FACTUAL; HUMANS; REGISTRIES;

EID: 84927691073     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000113     Document Type: Review

References (57)

1. Knerr V, Grimbacher B. Primary immunodeficiency registries [review]. Curr Opin Allergy Clin Immunol 2007; 7:475-480.
2. Samarghitean C, Vihinen M. Bioinformatics services related to diagnosis of primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2009; 9:531-536.
3. Chinnabhandar V, Yadav SP, Kaul D, et al. Primary immunodeficiency disorders in the developing world: data from a hospital-based registry in India. Pediatr Hematol Oncol 2014; 31:207-211.
4. Madkaikar M, Mishra A, Desai M, et al. Comprehensive report of primary immunodeficiency disorders from a tertiary care center in India. J Clin Immunol 2013; 33:507-512.
5. Gupta S, Madkaikar M, Singh S, Sehgal S. Primary immunodeficiencies in India: a perspective. Ann N Y Acad Sci 2012; 1250:73-79.
6. Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in oman: five years' experience at sultan qaboos university hospital. World Allergy Organ J 2012; 5:52-56.
7. Lee PP, Lau YL. Endemic infections in Southeast Asia provide new insights to the phenotypic spectrum of primary immunodeficiency disorders. Asian Pac J Allergy Immunol 2013; 31:217-260.
8. Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy Asthma Immunol Res 2013; 5:88-95.
9. Noh LM, Nasuruddin BA, Abdul Latiff AH, et al. Clinical-epidemiological pattern of primary immunodeficiencies in Malaysia 1987-2006: a 20 year experience in four Malaysian hospitals. Med J Malaysia 2013; 68:13-17.
10. CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol 2010; 135:264-272.
11. European Society for Immunodeficiencies. http://www.esid.org/working-parties/registry/ESID-Database-Statistics. [Accessed 28 August 2014]
12. Gathmann B, Goldacker S, Klima M, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol 2013; 173:372-380.
13. PID Registry. http://www.pid-net.org/registry/. [Accessed 09 July 2014]
14. Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol 2014; 34:478-490.
15. Cineca. http://www.cineca.it/en. [Accessed 22 June 2014]
16. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-316.
17. Carsetti R, Rosado MM, Donnanno S, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115:412-417.
18. Plebani A, Soresina A, Rondelli R, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicentre study. Clin Immunol 2002; 104:221-230.
19. Cancrini C, Puliafito P, Digilio MC, et al. Clinical features and follow-up in patients with 22q 11.2 deletion syndrome. J Pediatr 2014; 164:1475-1480.
20. Moschese V, Martire B, Soresina A, et al. Antiinfective prophylaxis for primary immunodeficiencies: what is done in Italian Primary Immunodeficiency Network centers (IPINet) and review of the literature. J Biol Regul Homeost Agents 2013; 27:935-946.
21. Quinti I, Soresina A, Guerra A, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011; 31:315-322.
22. Rhim JW, Kim KH, Kim DS, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci 2012; 27:788-793.
23. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J Clin Immunol 2008; 28:186-193.
24. Al-Herz W, Naguib KK, Notarangelo LD, et al. Parental consanguinity and the risk of primary immunodeficiency disorders: report from the Kuwait National Primary Immunodeficiency Disorders Registry. Int Arch Allergy Immunol 2011; 154:76-80.
25. Al-Herz W, Moussa MA. Survival and predictors of death among primary immunodeficient patients: a registry-based study. J Clin Immunol 2012; 32:467-473.
26. Bousfiha AA, Jeddane L, El Hafidi N, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012).
27. Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol 2013; 33:317-324.
28. REDIP. https://redip.org.es/redip/index.php?l=es&m=estadisticas. [Accessed 21 July 2014]
29. Kilic SS, Ozel M, Hafizoglu D, et al. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey: two centers study. J Clin Immunol 2013; 33:74-83.
30. Edgar JD, Buckland M, Guzman D, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol 2014; 175:68-78.
31. UKPIN. http://ukpin.org.uk/home/. [Accessed 22 June 2014]
32. ASCIA. http://www.immunodeficiency.org.au/about-register.html. [Accessed 22 June 2014]
33. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol 2007; 27:517-524.
34. Baumgart KW, Britton W, Kemp A, et al. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997; 100:415-423.
35. Vajdic CM, Mao L, van Leeuwen MT, et al. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood 2010; 116:1228-1234.
36. Guzman D, Veit D, Knerr V, et al. The ESID Online Database network. Bioinformatics 2007; 23:654-655.
37. Eades-Perner AM, Gathmann B, Knerr V, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 2007; 147:306-312.
38. Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134:116-126.e11.
39. Piirilä H, Väliaho J, Vihinen M. Immunodeficiency mutation databases (IDbases). Hum Mutat 2006; 27:1200-1208.
40. Riikonen P, Vihinen M. MUTbase: maintenance and analysis of distributed mutation databases. Bioinformatics 1999; 15:852-859.
41. Leiva LE, Zelazco M, Oleastro M, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007; 27:101-108.
42. Condino-Neto A, Franco JL, Espinosa-Rosales FJ, et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) initiatives. Allergol Immunopathol (Madr) 2012; 40:187-193.
43. Cabral-Marques O, Klaver S, Schimke LF, et al. First report of the Hyper-IgM syndrome Registry of the Latin American Society for immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol 2014; 34:146-156.
44. Errante PR, Franco JL, Espinosa-Rosales FJ, et al. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci 2012; 1250:62-72.
45. IMS RIKEN Center for Integrative Medical Sciences. http://www.ims.riken.jp/english/projects/pj01.php. [Accessed 22 June 2014]
46. RAPID. http://web16.kazusa.or.jp/rapid/. [Accessed 13 July 2014]
47. SCETIDE. https://www.scetide.org/. [Accessed 22 June 2014]
48. Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 2010; 126:602-610.
49. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-169.
50. Sullivan KE, Puck JM, Notarangelo LD, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol 2014; 34:428-435.
51. European Society for Immunodeficiencies. http://esid.org/Working-Parties/Clinical. [Accessed 27 June 2014]
52. Bousfiha AA, Jeddane L, Ailal FA, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol 2013; 33:1078-1087.
53. European Society for Immunodeficiencies. http://esid.org/Working-Parties/Registry/Resources/Registry-Steering-Committee. [Accessed 29 June 2014]
54. European Society for Immunodeficiencies. http://esid.org/Working-Parties/Registry/Resources/Publications. [Accessed 29 June 2014]
55. USIDNET. http://usidnet.org/usidnet-registry/registry-data-query-form/. [Accessed 29 June 2014]
56. USIDNET. http://usidnet.org/committees/steering-committee/. [Accessed 29 June 2014]
57. Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2014; 5:162.